ID   PIM1_HUMAN              Reviewed;         404 AA.
AC   P11309; Q38RT9; Q5T7H7; Q96RG3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 3.
DT   05-OCT-2010, entry version 134.
DE   RecName: Full=Proto-oncogene serine/threonine-protein kinase pim-1;
DE            EC=2.7.11.1;
GN   Name=PIM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RX   MEDLINE=90382681; PubMed=2205533; DOI=10.1016/0378-1119(90)90195-W;
RA   Reeves R., Spies G.A., Kiefer M., Barr P.J., Power M.;
RT   "Primary structure of the putative human oncogene, pim-1.";
RL   Gene 90:303-307(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   MEDLINE=87277423; PubMed=3475233; DOI=10.1016/0378-1119(87)90352-0;
RA   Zakut-Houri R., Hazum S., Givol D., Telerman A.;
RT   "The cDNA sequence and gene analysis of the human pim oncogene.";
RL   Gene 54:105-111(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   MEDLINE=88217305; PubMed=3329709;
RA   Domen J., von Lindern M., Hermans A., Breuer M., Grosveld G.,
RA   Berns A.;
RT   "Comparison of the human and mouse PIM-1 cDNAs: nucleotide sequence
RT   and immunological identification of the in vitro synthesized PIM-1
RT   protein.";
RL   Oncogene Res. 1:103-112(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   MEDLINE=88115604; PubMed=3429489; DOI=10.1002/jcb.240350204;
RA   Meeker T.C., Nagarajan L., Ar-Rushdi A., Croce C.M.;
RT   "Cloning and characterization of the human PIM-1 gene: a putative
RT   oncogene related to the protein kinases.";
RL   J. Cell. Biochem. 35:105-112(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE INITIATION, TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND INTERACTION WITH BMX.
RX   PubMed=16186805; DOI=10.1038/sj.onc.1209058;
RA   Xie Y., Xu K., Dai B., Guo Z., Jiang T., Chen H., Qiu Y.;
RT   "The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase
RT   Etk/BMX and protects human prostate cancer cells from apoptosis
RT   induced by chemotherapeutic drugs.";
RL   Oncogene 25:70-78(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 92-293 (ISOFORM 2).
RX   MEDLINE=21354098; PubMed=11460166; DOI=10.1038/35085588;
RA   Pasqualucci L., Neumeister P., Goossens T., Nanjangud G.,
RA   Chaganti R.S.K., Kuppers R., Dalla-Favera R.;
RT   "Hypermutation of multiple proto-oncogenes in B-cell diffuse large-
RT   cell lymphomas.";
RL   Nature 412:341-346(2001).
RN   [10]
RP   CHARACTERIZATION.
RX   MEDLINE=88246418; PubMed=2837645;
RA   Telerman A., Amson R., Zakut-Houri R., Givol D.;
RT   "Identification of the human pim-1 gene product as a 33-kilodalton
RT   cytoplasmic protein with tyrosine kinase activity.";
RL   Mol. Cell. Biol. 8:1498-1503(1988).
RN   [11]
RP   FUNCTION.
RX   PubMed=1825810;
RA   Saris C.J., Domen J., Berns A.;
RT   "The pim-1 oncogene encodes two related protein-serine/threonine
RT   kinases by alternative initiation at AUG and CUG.";
RL   EMBO J. 10:655-664(1991).
RN   [12]
RP   FUNCTION.
RX   MEDLINE=20130009; PubMed=10664448; DOI=10.1016/S0014-5793(00)01105-4;
RA   Koike N., Maita H., Taira T., Ariga H., Iguchi-Ariga S.M.M.;
RT   "Identification of heterochromatin protein 1 (HP1) as a
RT   phosphorylation target by Pim-1 kinase and the effect of
RT   phosphorylation on the transcriptional repression function of HP1.";
RL   FEBS Lett. 467:17-21(2000).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   MEDLINE=22567470; PubMed=12680209;
RA   Ionov Y., Le X., Tunquist B.J., Sweetenham J., Sachs T., Ryder J.,
RA   Johnson T., Lilly M.B., Kraft A.S.;
RT   "Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear
RT   localization is necessary for its biologic effects.";
RL   Anticancer Res. 23:167-178(2003).
RN   [14]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=15528381;
RA   Stout B.A., Bates M.E., Liu L.Y., Farrington N.N., Bertics P.J.;
RT   "IL-5 and granulocyte-macrophage colony-stimulating factor activate
RT   STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in
RT   human eosinophils.";
RL   J. Immunol. 173:6409-6417(2004).
RN   [15]
RP   FUNCTION IN CELL CYCLE PROGRESSION, INTERACTION WITH CDKN1B AND FOXO3,
RP   AND PHOSPHORYLATION OF CDKN1B AND FOXO3.
RX   PubMed=18593906; DOI=10.1158/0008-5472.CAN-08-0634;
RA   Morishita D., Katayama R., Sekimizu K., Tsuruo T., Fujita N.;
RT   "Pim kinases promote cell cycle progression by phosphorylating and
RT   down-regulating p27Kip1 at the transcriptional and posttranscriptional
RT   levels.";
RL   Cancer Res. 68:5076-5085(2008).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-144; GLN-215; LYS-226 AND ASP-233.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May affect the structure or silencing of chromatin by
CC       phosphorylating HP1 gamma/CBX3. Isoform 2 promotes the G1/S
CC       transition of the cell cycle via up-regulation of CDK2 activity
CC       and phosphorylation of CDKN1B, resulting in enhanced nuclear
CC       export and proteasome-dependent degradation of CDKN1B. Isoform 2
CC       also represses CDKN1B transcription by phosphorylating and
CC       inactivating the transcription factor FOXO3. Plays a role in
CC       signal transduction in blood cells. Contributes to both cell
CC       proliferation and survival and thus provides a selective advantage
CC       in tumorigenesis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Manganese.
CC   -!- SUBUNIT: Binds to RP9. Isoform 2 is isolated as a monomer whereas
CC       isoform 1 complexes with other proteins. Isoform 1, but not
CC       isoform 2, binds BMX. Isoform 2 interacts with CDKN1B and FOXO3.
CC   -!- INTERACTION:
CC       Q9UNQ0:ABCG2; NbExp=7; IntAct=EBI-696621, EBI-1569435;
CC       P51813:BMX; NbExp=2; IntAct=EBI-696621, EBI-696657;
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11309-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11309-2; Sequence=VSP_016530;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in cells of the
CC       hematopoietic and germline lineages. Isoform 1 and isoform 2 are
CC       both expressed in prostate cancer cell lines.
CC   -!- INDUCTION: Strongly induced in leukocytes by the JAK/STAT pathway
CC       in response to cytokines.
CC   -!- PTM: Autophosphorylated on both serine/threonine and tyrosine
CC       residues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. PIM subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PIM1ID261.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M27903; AAA60090.1; -; Genomic_DNA.
DR   EMBL; M16750; AAA60089.1; -; mRNA.
DR   EMBL; M54915; AAA36447.1; -; mRNA.
DR   EMBL; M24779; AAA81553.1; -; mRNA.
DR   EMBL; DQ022562; AAY87461.1; -; mRNA.
DR   EMBL; AL353579; CAI20316.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03934.1; -; Genomic_DNA.
DR   EMBL; BC020224; AAH20224.1; -; mRNA.
DR   EMBL; AF386792; AAK70871.1; -; Genomic_DNA.
DR   IPI; IPI00005014; -.
DR   IPI; IPI00745060; -.
DR   PIR; JU0327; TVHUP1.
DR   RefSeq; NP_002639.1; -.
DR   UniGene; Hs.81170; -.
DR   PDB; 1XQZ; X-ray; 2.10 A; A=105-404.
DR   PDB; 1XR1; X-ray; 2.10 A; A=105-404.
DR   PDB; 1XWS; X-ray; 1.80 A; A=92-404.
DR   PDB; 1YHS; X-ray; 2.15 A; A=124-396.
DR   PDB; 1YI3; X-ray; 2.50 A; A=124-396.
DR   PDB; 1YI4; X-ray; 2.40 A; A=124-396.
DR   PDB; 1YWV; X-ray; 2.00 A; A=120-404.
DR   PDB; 1YXS; X-ray; 2.20 A; A=120-404.
DR   PDB; 1YXT; X-ray; 2.00 A; A=120-404.
DR   PDB; 1YXU; X-ray; 2.24 A; A/B/C/D=120-404.
DR   PDB; 1YXV; X-ray; 2.00 A; A=120-404.
DR   PDB; 1YXX; X-ray; 2.00 A; A=120-404.
DR   PDB; 2BIK; X-ray; 1.80 A; B=92-404.
DR   PDB; 2BIL; X-ray; 2.55 A; B=92-404.
DR   PDB; 2BZH; X-ray; 1.90 A; B=92-404.
DR   PDB; 2BZI; X-ray; 1.90 A; B=92-404.
DR   PDB; 2BZJ; X-ray; 2.05 A; A=92-404.
DR   PDB; 2BZK; X-ray; 2.45 A; B=92-404.
DR   PDB; 2C3I; X-ray; 1.90 A; B=92-404.
DR   PDB; 2J2I; X-ray; 1.90 A; B=92-403.
DR   PDB; 2O3P; X-ray; 2.24 A; A=120-404.
DR   PDB; 2O63; X-ray; 2.00 A; A=120-404.
DR   PDB; 2O64; X-ray; 2.44 A; A=120-404.
DR   PDB; 2O65; X-ray; 2.85 A; A=120-404.
DR   PDB; 2OBJ; X-ray; 2.50 A; A=92-404.
DR   PDB; 2OI4; X-ray; 2.20 A; X=92-404.
DR   PDB; 3BGP; X-ray; 2.80 A; A=92-404.
DR   PDB; 3BGQ; X-ray; 2.00 A; A=92-404.
DR   PDB; 3BGZ; X-ray; 2.40 A; A=92-404.
DR   PDB; 3BWF; X-ray; 2.35 A; A=92-404.
DR   PDB; 3C4E; X-ray; 1.98 A; A/B/C/D=124-396.
DR   PDB; 3CXW; X-ray; 2.10 A; A=92-404.
DR   PDB; 3CY2; X-ray; 2.01 A; A=92-404.
DR   PDB; 3CY3; X-ray; 2.15 A; A=92-404.
DR   PDB; 3DCV; X-ray; 2.70 A; A=93-404.
DR   PDB; 3F2A; X-ray; 1.90 A; A=105-404.
DR   PDB; 3JPV; X-ray; 2.35 A; A=92-403.
DR   PDB; 3JXW; X-ray; 2.80 A; A=120-404.
DR   PDB; 3JY0; X-ray; 2.40 A; A=120-404.
DR   PDB; 3JYA; X-ray; 2.10 A; A=120-404.
DR   PDB; 3MA3; X-ray; 2.30 A; A=92-403.
DR   PDBsum; 1XQZ; -.
DR   PDBsum; 1XR1; -.
DR   PDBsum; 1XWS; -.
DR   PDBsum; 1YHS; -.
DR   PDBsum; 1YI3; -.
DR   PDBsum; 1YI4; -.
DR   PDBsum; 1YWV; -.
DR   PDBsum; 1YXS; -.
DR   PDBsum; 1YXT; -.
DR   PDBsum; 1YXU; -.
DR   PDBsum; 1YXV; -.
DR   PDBsum; 1YXX; -.
DR   PDBsum; 2BIK; -.
DR   PDBsum; 2BIL; -.
DR   PDBsum; 2BZH; -.
DR   PDBsum; 2BZI; -.
DR   PDBsum; 2BZJ; -.
DR   PDBsum; 2BZK; -.
DR   PDBsum; 2C3I; -.
DR   PDBsum; 2J2I; -.
DR   PDBsum; 2O3P; -.
DR   PDBsum; 2O63; -.
DR   PDBsum; 2O64; -.
DR   PDBsum; 2O65; -.
DR   PDBsum; 2OBJ; -.
DR   PDBsum; 2OI4; -.
DR   PDBsum; 3BGP; -.
DR   PDBsum; 3BGQ; -.
DR   PDBsum; 3BGZ; -.
DR   PDBsum; 3BWF; -.
DR   PDBsum; 3C4E; -.
DR   PDBsum; 3CXW; -.
DR   PDBsum; 3CY2; -.
DR   PDBsum; 3CY3; -.
DR   PDBsum; 3DCV; -.
DR   PDBsum; 3F2A; -.
DR   PDBsum; 3JPV; -.
DR   PDBsum; 3JXW; -.
DR   PDBsum; 3JY0; -.
DR   PDBsum; 3JYA; -.
DR   PDBsum; 3MA3; -.
DR   ProteinModelPortal; P11309; -.
DR   DisProt; DP00322; -.
DR   IntAct; P11309; 29.
DR   MINT; MINT-1412755; -.
DR   STRING; P11309; -.
DR   PhosphoSite; P11309; -.
DR   PRIDE; P11309; -.
DR   Ensembl; ENST00000373507; ENSP00000362606; ENSG00000137193.
DR   GeneID; 5292; -.
DR   KEGG; hsa:5292; -.
DR   CTD; 5292; -.
DR   GeneCards; GC06P037184; -.
DR   HGNC; HGNC:8986; PIM1.
DR   HPA; CAB017040; -.
DR   HPA; HPA003941; -.
DR   MIM; 164960; gene.
DR   PharmGKB; PA33318; -.
DR   eggNOG; prNOG13061; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG106681; -.
DR   InParanoid; P11309; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   NextBio; 20450; -.
DR   ArrayExpress; P11309; -.
DR   Bgee; P11309; -.
DR   CleanEx; HS_PIM1; -.
DR   Genevestigator; P11309; -.
DR   GermOnline; ENSG00000137193; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organismal development; TAS:ProtInc.
DR   GO; GO:0043066; P:negative regulation of apoptosis; IDA:UniProtKB.
DR   GO; GO:0043433; P:negative regulation of transcription factor...; IDA:UniProtKB.
DR   GO; GO:0031659; P:positive regulation of cyclin-dependent pro...; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR017348; STPK_Pim-1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037993; STPK_Pim-1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; ATP-binding; Cell cycle;
KW   Cell membrane; Complete proteome; Cytoplasm; Kinase; Manganese;
KW   Membrane; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    404       Proto-oncogene serine/threonine-protein
FT                                kinase pim-1.
FT                                /FTId=PRO_0000043349.
FT   DOMAIN      129    381       Protein kinase.
FT   NP_BIND     135    143       ATP (By similarity).
FT   ACT_SITE    258    258       Proton acceptor (By similarity).
FT   BINDING     158    158       ATP (By similarity).
FT   VAR_SEQ       1     91       Missing (in isoform 2).
FT                                /FTId=VSP_016530.
FT   VARIANT     144    144       Y -> H (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041004.
FT   VARIANT     215    215       E -> Q.
FT                                /FTId=VAR_041005.
FT   VARIANT     226    226       E -> K.
FT                                /FTId=VAR_041006.
FT   VARIANT     233    233       E -> D.
FT                                /FTId=VAR_041007.
FT   CONFLICT    106    107       AP -> RA (in Ref. 2; AAA60089).
FT   TURN        126    128
FT   STRAND      129    140
FT   STRAND      142    148
FT   TURN        149    151
FT   STRAND      154    161
FT   TURN        162    164
FT   STRAND      168    170
FT   STRAND      176    178
FT   HELIX       179    187
FT   STRAND      197    202
FT   STRAND      204    212
FT   STRAND      215    219
FT   HELIX       220    227
FT   HELIX       232    251
FT   HELIX       261    263
FT   STRAND      264    267
FT   TURN        268    271
FT   STRAND      272    275
FT   HELIX       296    298
FT   HELIX       301    306
FT   HELIX       311    328
FT   HELIX       336    341
FT   HELIX       352    361
FT   HELIX       366    368
FT   HELIX       372    377
FT   HELIX       379    381
FT   HELIX       387    394
SQ   SEQUENCE   404 AA;  45412 MW;  18C421B7CFF87818 CRC64;
     MPHEPHEPLT PPFSALPDPA GAPSRRQSRQ RPQLSSDSPS AFRASRSHSR NATRSHSHSH
     SPRHSLRHSP GSGSCGSSSG HRPCADILEV GMLLSKINSL AHLRAAPCND LHATKLAPGK
     EKEPLESQYQ VGPLLGSGGF GSVYSGIRVS DNLPVAIKHV EKDRISDWGE LPNGTRVPME
     VVLLKKVSSG FSGVIRLLDW FERPDSFVLI LERPEPVQDL FDFITERGAL QEELARSFFW
     QVLEAVRHCH NCGVLHRDIK DENILIDLNR GELKLIDFGS GALLKDTVYT DFDGTRVYSP
     PEWIRYHRYH GRSAAVWSLG ILLYDMVCGD IPFEHDEEII RGQVFFRQRV SSECQHLIRW
     CLALRPSDRP TFEEIQNHPW MQDVLLPQET AEIHLHSLSP GPSK
//
